0000950133-06-003817 Sample Contracts

AMENDED AND RESTATED MARKETING AGREEMENT
Marketing Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Michigan

THIS AMENDED AND RESTATED MARKETING AGREEMENT (the “Agreement”) is made effective this 1st day of January 2000 (the “Effective Date”), by and between BioPort Corporation, a Michigan corporation having its principal office at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 (“BIOPORT”) and INTERGEN N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles (“INTERGEN”) (BIOPORT and INTERGEN being sometimes referred to in the singular as “Party” and collectively as “Parties”).

Sample 1Sample 2
AutoNDA by SimpleDocs
VOTING AGREEMENT
Voting Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

VOTING AGREEMENT, effective as of June 30, 2004 (this “Agreement”), by and between BIOPHARM, LLC, a Delaware limited liability company (“BioPharm”) and Michigan Biologics Products, Inc., a Michigan corporation (“MBPI”).

Sample 1Sample 2
DATED 13th December 1996 SLOUGH PROPERTIES LIMITED - to - AZUR ENVIRONMENTAL LIMITED LEASE Premises known as Winnersh 540 Winnersh Triangle Wokingham Berkshire Nabarro Nathanson 50 Stratton Street London WIX 6NX Tel: 0171 493 9933 JE/JUS/S2883/224/lms...
Emergent BioSolutions Inc. • August 14th, 2006
Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. BT VACCINE DEVELOPMENT AGREEMENT
Vaccine Development Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York

THIS BT VACCINE DEVELOPMENT AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“HPA”) (each of Emergent and HPA, a “Party”).

Sample 1
AMENDED AND RESTATED LOAN AGREEMENT
Loan Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Michigan

THIS AMENDED AND RESTATED LOAN AGREEMENT is made as of July 29th, 2005, by and between BIOPORT CORPORATION, a Michigan corporation, of Lansing, Michigan (“Borrower”), and FIFTH THIRD BANK, a Michigan banking corporation, of East Lansing, Michigan (“Lender”).

Sample 1
STANDARD EMPLOYMENT CONTRACT
Employment Contract • August 14th, 2006 • Emergent BioSolutions Inc.

This statement sets out the Terms & Conditions of employment between Emergent Europe Limited of 540~545 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TU , UK

Sample 1
Confidential Materials omitted and filed separately with the Securites and Exchange Commission. Asterisks denote omissions. BT VACCINE LICENSE AGREEMENT
Vaccine License Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York

THIS BT VACCINE LICENSE AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“HPA”) (each of Emergent and HPA, a “Party”).

Sample 1
LEASE BY AND BETWEEN ARE-QRS, CORP. as Landlord and ANTEX BIOLOGICS INC. as Tenant
Lease • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

THIS LEASE is made as of December 1, 1998 (“Effective Date”), by and between ARE-QRS CORP., a Maryland corporation (“Landlord”) and ANTEX BIOLOGICS INC., a Delaware (“Tenant”).

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. DATED 18th Day of March 2005 AND AND INVESTMENT AGREEMENT RELATING TO MICROSCIENCE HOLDINGS PLC Ref: NKM/SJM/WELTR.0011
Investment Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • England
Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York

THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc. a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“Supplier”) (each of Emergent and Supplier, a “Party”).

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. rBOT VACCINE DEVELOPMENT AGREEMENT
Rbot Vaccine Development Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York

THIS rBOT VACCINE DEVELOPMENT AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“HPA”) (each of Emergent and HPA, a “Party”).

Sample 1
COUNTY COMMISSIONERS OF FREDERICK COUNTY, EMERGENT BIOLOGICS INC. a n d MERCANTILE POTOMAC BANK BOND PURCHASE AGREEMENT Dated as of March 31, 2005 Frederick County, Maryland Tax Increment Financing Bonds (Dudrow Industrial Park Lot Three Development...
Bond Purchase Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

The undersigned (herein called the “Purchaser”) hereby offers to enter into this Bond Purchase Agreement with you for the purchase and sale of the Tax Increment Financing Bonds (Dudrow Industrial Park Lot Three Development District) Series 2005 (the “Bonds”) described below. This offer is made subject to acceptance by County Commissioners of Frederick County (the “Issuer”) and Emergent Biologics Inc. (formerly Advanced BioSolutions, Inc.) (the “Company”). Upon such acceptance, this Bond Purchase Agreement shall become effective in accordance with its terms and shall become binding between you and the undersigned Purchaser.

Sample 1
INDEMNITY AGREEMENT
Indemnity Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

This Indemnity Agreement is made this___day of , 2005, by and between Emergent BioSolutions Inc. a Delaware corporation (the “Company”), and , (the “Indemnitee”).

Sample 1
LOAN AGREEMENT
Loan Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

THIS LOAN AGREEMENT (as it may be amended, this “Agreement”) is made as of this ___ day of , 2004, between ADVANCED BIOSOLUTIONS, INC., a Maryland corporation (the “Borrower”), and the DEPARTMENT OF BUSINESS AND ECONOMIC DEVELOPMENT, a principal department of the State of Maryland (the “Lender”).

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Development Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

EMERGENT EUROPE LIMITED, a company organised and existing under the laws of England (Company number 03270465) and having its registered office at 545 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire, RG41 5TU (“Emergent”);

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc. • August 14th, 2006

PAGE OF PAGES — 1 26 —— — 2. CONTRACT NUMBER 3. SOLICITATION NUMBER 5. DATE ISSUED 6. REQUISITION/PURCHASE NUMBER W9113M-04-D-0002 W9113M-0R-4-0004 4. TYPE OF SOLICITATION 11/18/2003 W90GXK33010005 —— —— —— — ¨ SEALED BID (IFB) ¨ NEGOTIATED (RFP) — 7. ISSUED BY CODE W9113M 8. ADDRESS OFFER TO (if other than Item 7) —— Same — US Army Space and Missile Defense Command, 64 Thomas Johnson Drive Frederick, MD 21702 — NOTE: In sealed bid solicitations “offer” and “offeror” mean “bid” and “bidder”. — SOLICITATION — 9. Sealed offers in original and copies for furnishing the supplies or services in the Schedule will be received at the place specified in Item 8, or if handcarried, in the depository located in until local time (Hour) (Date) CAUTION — LATE Submissions, Modifications, and Withdrawals: See Section L, Provision No. 52.214-7 or 52.215-1. All offers are subject to all terms and conditions contained in this solicitation. — 10. FOR INFORMATION A. NAME C. E-MAIL ADDRESS CALL: Lynn M. Self

Sample 1
VOTING AND RIGHT OF FIRST REFUSAL AGREEMENT
Voting and Right of First Refusal Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

VOTING AND RIGHT OF FIRST REFUSAL AGREEMENT, effective as of October 21, 2005 (this “Agreement”), by and among the William J. Crowe, Jr. Revocable Living Trust (the “Trust”) and Mr. Fuad El-Hibri (the “Mr. El-Hibri”).

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. rBOT VACCINE LICENSE AGREEMENT
Rbot Vaccine License Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York

THIS rBOT VACCINE LICENSE AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“HPA”) (each of Emergent and HPA, a “Party”).

Sample 1
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

THIS REGISTRATION RIGHTS AGREEMENT is made as of June 23, 2005, by and among EMERGENT BIOSOLUTIONS INC., a Delaware corporation (together with any successor thereto, the “Company”), and MICROSCIENCE HOLDINGS PLC, a public limited company organized under the laws of the United Kingdom (“PLC”). Each of the Company and PLC are referred to herein as a “Party” and collectively, as the “Parties”.

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. FILLING SERVICES AGREEMENT
Filling Services Agreement • August 14th, 2006 • Emergent BioSolutions Inc.

This Agreement is made this 18th day of March, 2002 (the “Effective Date”), by and between BioPort Corporation, a Michigan corporation having its principal office at 3500 North Martin Luther King Jr. Blvd., Lansing, MI 48906 (“BIOPORT”) and HOLLISTER-STIER Laboratories LLC, a Delaware limited liability company having its principal office at 3525 North Regal Street, Spokane, WA 99207 (“HOLLISTER-STIER”) (sometimes referred to in the singular as “Party” and collectively as the “Parties”).

Sample 1
LOAN AGREEMENT
Loan Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

THIS LOAN AGREEMENT (this “Agreement”) is dated as of April 25th 2006, by and among EMERGENT FREDERICK LLC, a Maryland limited liability company, which maintains its chief executive office at 300 Professional Drive, Suite 100, Gaithersburg, Maryland 20879 (the “Borrower”), and EMERGENT BIOSOLUTIONS INC., a Delaware corporation (the “Guarantor”) and HSBC REALTY CREDIT CORPORATION (USA), a Delaware corporation (the “Bank”).

Sample 1
LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Maryland

THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated this 14th day of October, 2004, by and among ADVANCED BIOSOLUTIONS, INC., a Maryland corporation, which maintains its chief executive office at c/o Antex Biologics Inc., 300 Professional Drive, Suite 100, Gaithersburg, Maryland 20879 (the “Borrower” which term shall mean the “Debtor” as defined under the Maryland Uniform Commercial Code), ANTEX BIOLOGICS INC., a Delaware corporation, BIOPORT CORPORATION, a Michigan corporation and EMERGENT BIOSOLUTIONS INC., a Delaware corporation (individually or collectively, the “Guarantor”) and MERCANTILE POTOMAC BANK (the “Bank” which term shall mean the “Secured Party” as defined in the Maryland Uniform Commercial Code).

Sample 1
AutoNDA by SimpleDocs
VOTING AGREEMENT
Voting Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

VOTING AGREEMENT, effective as of June 30, 2004 (this “Agreement”), by and among the stockholders of Emergent BioSolutions Inc. (the “Company”) named on Schedule 1 attached hereto (each a “Stockholder” and collectively, the “Stockholders”).

Sample 1
EMERGENT BIOSOLUTIONS INC. DIRECTOR STOCK OPTION AGREEMENT
Director Stock Option Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

A Stock Option award (hereinafter, “Stock Option” or “Option”) is hereby granted by Emergent BioSolutions Inc., a Delaware corporation (“Company”), to the Director named below (“Optionee”), for and with respect to the Class B nonvoting common stock of the Company (“Common Stock”), subject to the terms and conditions contained in this Agreement (“Option Agreement”).

Sample 1
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. CONSULTING SERVICES AGREEMENT
Consulting Services Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • Delaware

This Recruiting Services Agreement (“Agreement”) is made effective the 1st day of March 2006, by and between EMERGENT BIOSOLUTIONS INC., with offices at 300 Professional Drive, Gaithersburg, Maryland 20879 (“EMERGENT”), and The Hauer Group with offices at 7850 Southdown Road, Alexandria, VA 22308 (“Consultant”) (sometimes referred to in the singular as “Party” and collectively as the “Parties”).

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!